In this study, we evaluated the antioxidant effect of Sn-HSA on ROS induced by myoglobin in kidney cells to assess whether Sn-HSA has the potential to treat rhabdomyolysis-induced AKI. The gene discussed is ALB; the disease is rhabdomyolysis.